NTRB - שווי שוק לנפח מכירות Nutriband Corp

Nutriband Inc. is developing transdermal systems to combat drug abuse, mitigating patent risks through the diversification of analgesics. The current P/S valuation, as illustrated in this GURU.Markets chart, confirms the potential, with 46.00 serving as the current metric level. Stability is supported by a staff of specialized engineers, while environmental risks are minimized through medical waste control and the implementation of biodegradable packaging.

For Nutriband Inc. (NTRB), which is currently preparing for the commercial launch of its transdermal systems, the P/S ratio serves as a key indicator of market expectations. This metric is calculated as the ratio of market capitalization to total sales, measuring the value of each unit of revenue. Analyzing the chronology of P/S values allows for tracking the business valuation dynamics relative to industry medians, which is critical for a startup whose current value is based on the potential for FDA approval.